The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma - Egyptian Knowledge Bank - troweb

5454

The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

Preablative stimulated Thyroglobulin (sTg) versus sTg/TSH ratio in prediction of ablation outcome in patients with papillary thyroid cancer

Article

Added value of I131 SPECT/CT imaging after I-131 ablation in patient with differentiated thyroid cancer

Article

Prognostic Value of FDG PET/CT in Differentiated Thyroid Cancer Patients

Article

Impact of Post-Thyroidectomy I-123 Versus I-131 Whole Body Scan on the Outcome of Radioactive Iodine (I-131) Ablation for Differentiated Thyroid Carcinoma

Article

Low and High Radio-Iodine-131 Doses in Postoperative Ablation in Differentiated Thyroid Carcinoma

Article

Impact of Ablative Low Dose Radio-Active Iodine after Thyroidectomy in Low–Risk Differentiated Thyroid Cancer

Article

Ablation outcomes of low versus high doses of radioiodine ( I) in patients with differentiated thyroid carcinoma following thyroidectomy

Article

Effect of Different Ablative Doses of Radioactive Iodine in Patients with Differentiated Thyroid Carcinoma and Cervical Lymph Node Metastasis

Article

Assessment of Different Radioactive Iodine Ablation Strategies in Intermediate and High Risk Papillary Thyroid Cancer

Article

Factors affecting ablation outcome in low and intermediate risk patients with differentiated thyroid cancer.